{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:38:22Z","timestamp":1787827102521,"version":"build-2784847793"},"reference-count":44,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1080\/13696998.2018.1542599","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T15:24:52Z","timestamp":1540913092000},"page":"117-130","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage III or IV classical Hodgkin lymphoma"],"prefix":"10.1080","volume":"22","clinical-trial-number":[{"clinical-trial-number":"nct01712490","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Thomas E.","family":"Delea","sequence":"first","affiliation":[{"name":"Policy Analysis Inc. (PAI), Brookline, MA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arati","family":"Sharma","sequence":"additional","affiliation":[{"name":"Policy Analysis Inc. (PAI), Brookline, MA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Grossman","sequence":"additional","affiliation":[{"name":"Policy Analysis Inc. (PAI), Brookline, MA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Eichten","sequence":"additional","affiliation":[{"name":"Policy Analysis Inc. (PAI), Brookline, MA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keenan","family":"Fenton","sequence":"additional","affiliation":[{"name":"Seattle Genetics Inc., Seattle, WA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Josephson","sequence":"additional","affiliation":[{"name":"Seattle Genetics Inc., Seattle, WA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshara","family":"Richhariya","sequence":"additional","affiliation":[{"name":"Seattle Genetics Inc., Seattle, WA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison J.","family":"Moskowitz","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,12,10]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21438"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24272"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.7243"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.2.617"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1980.03300300025019"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-02-699850"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.07.018"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-595801"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70013-6"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60165-9"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.0410"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.2657.2657"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.11.688"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30818"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708984"},{"key":"CIT0016","unstructured":"ADCETRIS\u00ae (brentuximab vedotin) for injection, for intravenous use [full prescribing information]. Initial U.S. approval: 2011. Revised: 03\/2018. Seattle, WA: Seattle Genetics. Available at: http:\/\/www.seattlegenetics.com\/application\/files\/1915\/2157\/0234\/adcetris_USPI.pdf [Last accessed June 25, 2018]"},{"key":"CIT0017","volume-title":"CPI-All urban consumers. Medical care in US city average, all urban","author":"Bureau of Labor Statistics","year":"2018"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu387"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1048208"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12973"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1030639"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14245"},{"key":"CIT0023","volume-title":"Market research. Data on file","author":"Seattle Genetics","year":"2018"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.07.131"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.970542"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14316"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-7596-1_3"},{"key":"CIT0028","unstructured":"Centers for Medicare & Medicaid Services. Physician fee schedule. 2018"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30167-X"},{"key":"CIT0030","author":"Truven Health Analytics","year":"2017","journal-title":"Truven Health Analytics"},{"key":"CIT0031","volume-title":"ECHELON 1: Phase 3 frontline therapy trial in patients with advanced Hodgkin Lymphoma","author":"Millenium Pharmaceuticals Inc","year":"2017"},{"key":"CIT0032","volume-title":"National inpatient sample. Inpatient costs extracted using ICD-9 codes","author":"Healthcare Cost","year":"2018"},{"key":"CIT0033","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood-2017-10-812966","volume":"130","author":"Straus DJ","year":"2017","journal-title":"Blood"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.2368.2368"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1405158"},{"key":"CIT0036","unstructured":"Neumann PJ, Cohen JT. America\u2019s \u201cNICE\u201d? Health Affairs Blog. March 12, Health Affairs Blog, Bethesda, MD 2018. Available at: https:\/\/www.healthaffairs.org\/do\/10.1377\/hblog20180306.837580\/full\/[Last accessed September 26, 2018]"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.14.1637"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e31815c31a7"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X0002000310"},{"key":"CIT0040","first-page":"1086","volume":"20","author":"Bae YH","year":"2014","journal-title":"J Manag Care Spec Pharm"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21995"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp478"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-7-24"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.6609"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2018.1542599","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T22:09:36Z","timestamp":1599430176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2018.1542599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,10]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,1]]}},"alternative-id":["10.1080\/13696998.2018.1542599"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2018.1542599","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-08-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}